No MI, Mortality Threat From Echo Contrast Agents in Meta-Analysis

The study suggests that the perflutren-containing contrast agents present no untoward risk that justifies restrictions on their current indications, researchers say. Heartwire

...

More on Sciencestage.com

    More on Wikipedia

      Related Videos

        More on answers.yahoo.com

        More on Pubmed

          More on Answers.com